Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,073 | 5 | 91.3% |
| Travel and Lodging | $1,590 | 7 | 8.0% |
| Food and Beverage | $99.66 | 4 | 0.5% |
| Unspecified | $42.95 | 1 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $13,946 | 3 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $3,273 | 1 | $0 (2021) |
| Eli Lilly and Company | $1,000 | 2 | $0 (2018) |
| GENZYME CORPORATION | $769.97 | 2 | $0 (2018) |
| SANOFI US SERVICES INC. | $686.93 | 5 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $87.06 | 3 | $0 (2018) |
| Novartis Pharma AG | $42.95 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,200 | 1 | Genentech USA, Inc. ($7,200) |
| 2023 | $6,746 | 2 | Genentech USA, Inc. ($6,746) |
| 2021 | $3,273 | 1 | Regeneron Pharmaceuticals, Inc. ($3,273) |
| 2020 | $42.95 | 1 | Novartis Pharma AG ($42.95) |
| 2018 | $1,357 | 6 | GENZYME CORPORATION ($769.97) |
| 2017 | $1,187 | 6 | SANOFI US SERVICES INC. ($686.93) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | Genentech USA, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $7,200.00 | General |
| Category: Immunology | ||||||
| 12/01/2023 | Genentech USA, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $6,600.00 | General |
| Category: Immunology | ||||||
| 12/01/2023 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $145.77 | General |
| Category: Immunology | ||||||
| 02/12/2021 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,272.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2020 | Novartis Pharma AG | 10002149_XOLAIR _RESPIRATORY (Biological) | — | In-kind items and services | $42.95 | Research |
| Study: Publication support research related • Category: RESPIRATORY | ||||||
| 11/08/2018 | SANOFI-AVENTIS U.S. LLC | SAR439794 (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| 11/08/2018 | SANOFI-AVENTIS U.S. LLC | SAR439794 (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| 10/10/2018 | SANOFI-AVENTIS U.S. LLC | SAR439794 (Drug) | Food and Beverage | In-kind items and services | $43.43 | General |
| 10/09/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $434.97 | General |
| 10/09/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $335.00 | General |
| 04/27/2018 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 11/20/2017 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 07/01/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $320.46 | General |
| 07/01/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $268.96 | General |
| 07/01/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $51.67 | General |
| 07/01/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $33.24 | General |
| 07/01/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | Cash or cash equivalent | $12.60 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Publication support research related | Novartis Pharma AG | $42.95 | 1 |
About Dr. Robert Wood, M.D
Dr. Robert Wood, M.D is a Allergy healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508894221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Wood, M.D has received a total of $19,805 in payments from pharmaceutical and medical device companies, with $7,200 received in 2024. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($18,073).
Practice Information
- Specialty Allergy
- Other Specialties Pediatric Allergy/Immunology, Allergy
- Location Baltimore, MD
- Active Since 06/29/2006
- Last Updated 02/22/2013
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1508894221
Products in Payments
- Xolair (Biological) $13,946
- DUPIXENT (Biological) $3,273
- NO PRODUCT DISCUSSED (Drug) $1,457
- SAR439794 (Drug) $87.06
- 10002149_XOLAIR _RESPIRATORY (Biological) $42.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy Doctors in Baltimore
Sally Bailey, Md, MD
Allergy — Payments: $269,204
Dr. Jody Tversky, M.d, M.D
Allergy — Payments: $195,994
David Golden, M.d, M.D
Allergy — Payments: $132,282
Newton Adkinson, M.d, M.D
Allergy — Payments: $130,754
Peter Creticos, M.d, M.D
Allergy — Payments: $61,242
Dr. Gitika Dhillon
Allergy — Payments: $8,057